Immucell Stock Price Prediction
| ICCC Stock | USD 4.12 0.40 10.75% |
Oversold Vs Overbought
49
Oversold | Overbought |
Quarterly Earnings Growth (0.63) | Wall Street Target Price 14 | Quarterly Revenue Growth 0.549 |
Using ImmuCell hype-based prediction, you can estimate the value of ImmuCell from the perspective of ImmuCell response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in ImmuCell to buy its stock at a price that has no basis in reality. In that case, they are not buying ImmuCell because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ImmuCell after-hype prediction price | USD 4.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ImmuCell |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmuCell's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ImmuCell After-Hype Price Prediction Density Analysis
As far as predicting the price of ImmuCell at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ImmuCell or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ImmuCell, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ImmuCell Estimiated After-Hype Price Volatility
In the context of predicting ImmuCell's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ImmuCell's historical news coverage. ImmuCell's after-hype downside and upside margins for the prediction period are 2.27 and 5.97, respectively. We have considered ImmuCell's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ImmuCell is somewhat reliable at this time. Analysis and calculation of next after-hype price of ImmuCell is based on 3 months time horizon.
ImmuCell Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as ImmuCell is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ImmuCell backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ImmuCell, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 2.27 | 0.01 | 0.05 | 5 Events / Month | 2 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.12 | 4.12 | 0.00 |
|
ImmuCell Hype Timeline
ImmuCell is currently traded for 4.12. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.05. ImmuCell is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.16%. %. The volatility of related hype on ImmuCell is about 776.07%, with the expected price after the next announcement by competition of 4.17. About 40.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. ImmuCell has Price/Earnings (P/E) ratio of 195.0. The entity recorded a loss per share of 0.49. The firm had not issued any dividends in recent years. ImmuCell had 1:100 split on the 25th of July 1990. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out ImmuCell Basic Forecasting Models to cross-verify your projections.ImmuCell Related Hype Analysis
Having access to credible news sources related to ImmuCell's direct competition is more important than ever and may enhance your ability to predict ImmuCell's future price movements. Getting to know how ImmuCell's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ImmuCell may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CUE | Cue Biopharma | 0.02 | 8 per month | 5.91 | 0.11 | 20.27 | (11.51) | 67.78 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.70 | 0.02 | 5.54 | (6.11) | 16.80 | |
| MOLN | Molecular Partners AG | (0.10) | 5 per month | 0.00 | (0.02) | 9.38 | (8.53) | 52.92 |
ImmuCell Additional Predictive Modules
Most predictive techniques to examine ImmuCell price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ImmuCell using various technical indicators. When you analyze ImmuCell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ImmuCell Predictive Indicators
The successful prediction of ImmuCell stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ImmuCell, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ImmuCell based on analysis of ImmuCell hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ImmuCell's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ImmuCell's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 51.61 | 35.4 | 45.65 | 32.15 | PTB Ratio | 1.86 | 1.56 | 1.57 | 1.79 |
Story Coverage note for ImmuCell
The number of cover stories for ImmuCell depends on current market conditions and ImmuCell's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ImmuCell is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ImmuCell's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ImmuCell Short Properties
ImmuCell's future price predictability will typically decrease when ImmuCell's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ImmuCell often depends not only on the future outlook of the potential ImmuCell's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ImmuCell's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.7 M | |
| Cash And Short Term Investments | 978.7 K |
Complementary Tools for ImmuCell Stock analysis
When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |